ABSTRACT
Purpose
To evaluate the efficacy of mucoadhesive insulin-loaded whey protein (WP) /alginate (ALG) microparticles (MP) for oral insulin administration.
Methods
Insulin-loaded microparticles (ins-MP) made of whey protein and alginate were prepared by a cold gelation technique and an adsorption method, without adjunction of organic solvent in order to develop a biocompatible vehicle for oral administration of insulin. In vitro characterization, evaluations of ins-MP in excised intestinal tissues and hypoglycaemic effects after intestinal administration in healthy rats were performed
Results
The release properties and swelling behaviors, investigated in different pH buffers, demonstrated a release based on diffusion mechanism following matrix swelling. Mucoadhesion studies in rabbits and insulin transport experiments with excised intestinal rat tissues revealed that encapsulation in microparticles with mucoadhesive properties promotes insulin absorption across duodenal membranes and bioactivity protection. In vivo experiments reinforced the interest of encapsulation in whey protein/alginate combination. Confocal microscopic observations associated with blood glucose levels bring to light duodenal absorption of insulin biologically active following in vivo administration.
Conclusions
Insulin-loaded WP/ALG MP with high quantities of drug entrapped, in vitro matrix swelling and protective effect as well as excellent mucohadesive properties was developped. Improvement of intestinal delivery of insulin and increased in bioavailability were recorded.
Similar content being viewed by others
Abbreviations
- ALG:
-
alginate
- EE:
-
encapsulation efficiency
- ins-MP:
-
insulin-loaded microparticles
- MP:
-
microparticle
- WP:
-
whey protein
REFERENCES
Tan ML, Choong PFM, Dass CR. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides. 2010;31(1):184–93.
Wong TW. Design of oral insulin delivery systems. J Drug Targeting. 2010;18(2):79–92.
Lyer H, Khedkar A, Verma M. Oral insulin – a review of current status. Diabetes Obes Metab. 2010;12(3):179–85.
Khafagy ES, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev. 2007;59(15):1521–46.
Malafaya PB, Silva GA, Reis RL. Natural–origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev. 2007;59(4–5):207–33.
De Wit JN. Nutritional and functional characteristics of whey proteins in food products. J Dairy Sci. 1998;81(3):597–608.
Hongsprabhas P, Barbut S. Ca2+ -Induced cold gelation of whey protein isolate: effect of two-stage gelation. Food Res Int. 1998;30(7):523–7.
Beaulieu L, Savoie L, Paquin P, Subirade M. Elaboration and characterization of whey protein beads by an emulsification/cold gelation process: application for the protection of retinol. Biomacromolecules. 2002;3(2):239–48.
Hebrard G, Hoffart V, Cardot JM, Subirade M, Alric M, Beyssac E. Investigation of coated whey protein/alginate beads as sustained release dosage form in simulated gastrointestinal environment. Drug Dev Ind Pharm. 2009;35(9):1103–12.
Chen L, Subirade M. Alginate-whey protein granular microspheres as oral delivery vehicles for bioactive compounds. Biomaterials. 2006;27(26):4646–54.
Guerin D, Vuillemard JC, Subirade M. Protection of bifidobacteria encapsulated in polysaccharide–protein gel beads against gastric juice and bile. J Food Prot. 2003;66(11):2076–84.
Hebrard G, Blanquet S, Beyssac E, Remondetto G, Subirade M, Alric M. Use of whey protein beads as a new carrier system for recombinant yeasts in human digestive tract. J Biotechnol. 2006;127(1):151–60.
George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan, a review. J Control Release. 2006;114(1):1–14.
Beyssac E, Touaref F, Meyer M, Jacob L, Sandouk P, Aiache JM. Bioavailability of morphine after administration of a new bioadhesive buccal tablet. Biopharm Drug Dispos. 1998;19(6):401–5.
Builders PF, Kunle OO, Okpaku LC, Builders MI, Attama AA, Adikwu MU. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin. Eur J Pharm Biopharm. 2008;70(3):777–83.
Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug /polymer matrix swelling and dissolution. Pharm Res. 1998;5(8):488–94.
Rao Ranga KV, Buri BA. A novel in situ method to test polymers and coated microparticles for bioadhesion. Int J Pharm. 1989;52(3):265–70.
Garrait G, Jarrige JF, Blanquet S, Beyssac E, Cardot JM, Alric M. Gastrointestinal absorption and urinary excretion of trans-cinnamic and p-coumaric acids in rats. J Agric Food Chem. 2006;54(8):2944–50.
Whitehead K, Shen Z, Mitragotri S. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. J Control Release. 2004;98(1):37–45.
Zhao Y, Li F, Carvajal MT, Harris MT. Interactions between bovine serum albumin and alginate: an evaluation of alginate as protein carrier. J Colloid Interface Sci. 2009;332(2):345–53.
Hébrard G, Hoffard V, Beyssac E, Cardot JM, Alric M, Subirade M. Coated whey protein/alginate microparticles as oral controlled delivery systems for probiotic yeast. J Microencapsul. 2010;24(4):292–302.
Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm. 2006;323(1–2):34–42.
Remondetto GE, Beyssac E, Subirade M. Iron availability from whey protein hydrogels: an in vitro study. J Agric Food Chem. 2004;52(26):8137–43.
Ouwerx C, Veilings N, Mestdagh MM, Axelos MAV. Physico-chemical properties and rheology of alginate beads formed with various divalent cations. Polym Gel Netw. 1998;6(5):393–408.
Dorkoosh FA, Borchard G, Rafiee-Tehrani M, Verhoef JC, Junginger HE. Evaluation of superporous hydrogel (SPH) and SPH composites in porcine intestine ex vivo: assessment of drug transport, morphology effect, and mechanical fixation to intestinal wall. Eur J Pharm Biopharm. 2002;53(2):161–6.
Mortazavi SA, Smart JD. An investigation of some factors influencing the in vitro assessment of mucoadhesion. Int J Pharm. 1995;116(28):223–30.
Burjak M, Bogataj M, Velnar M, Grabnar I, Mrhar A. The study of drug release from microspheres adhered on pig vesical mucosa. Int J Pharm. 2001;224(1–2):123–30.
Dobrozsi DJ, Smith RL, Sakr AA. Comparative mucoretention of sucralfate suspensions in an everted rat esophagus model. Int J Pharm. 1999;189(1):81–9.
George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan. J Control Release. 2006;114(1):1–14.
Dodou D, Breedveld P, Wieringa PA. Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur J Pharm Biopharm. 2005;60(1):1–6.
Kavimandan NJ, Peppas NA. Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer. Int J Pharm. 2008;354:143–8.
Sajeesh S, Vauthier C, Gueutin C, Ponchel G, Sharma CP. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery. Acta Biomater. 2010;6(8):3072–80.
Cilek A, Celebi N, Tirnaksiz F, Tay A. A lecithin-based microemulsion of Rh insulin with aprotinin for oral administration: investigation of hypoglycaemic effects in non diabetic and STZ-induced diabetic rats. Int J Pharm. 2005;298(1):176–85.
Kim BY, Jeong JH, Park K, Kim JD. Bioadhesive interaction and hypoglycaemic effect of insulin-loaded lectin-microparticles conjugates in oral insulin delivery system. J Control Release. 2005;102(3):525–38.
Pauletti G, Gangwar S, Knipp GT, Nerurkar MM, Okuma FW, Tamura K, et al. Structural requirements for intestinal absorption of peptide drugs. J Control Release. 1996;41(1):3–17.
Lueβen HL, Bohner V, Perard D, Langguth P, Verhoef JC, de Boer AG, et al. Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly (acrylates) on the enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles. Int J Pharm. 1996;141(1–2):39–52.
Peppas NA. Devices based on intelligent biopolymers for oral protein delivery. Int J Pharm. 2004;277(1–2):11–7.
Schnurch AB, Kast CE. Chemically modified chitosans as enzyme inhibitors. Adv Drug Deliv Rev. 2001;52(2):127–37.
Yin L, Ding JY, Fei L, He M, Cui F, Tang C, et al. Beneficial properties for insulin absorption using superporous hydrogel containing interpenetrating polymer network as oral delivery vehicles. Int J Pharm Biopharm. 2008;350:220–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Déat-Lainé, E., Hoffart, V., Garrait, G. et al. Efficacy of Mucoadhesive Hydrogel Microparticles of Whey Protein and Alginate for Oral Insulin Delivery. Pharm Res 30, 721–734 (2013). https://doi.org/10.1007/s11095-012-0913-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-012-0913-3